Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Item 9 Labs (INLB) Current Deferred Revenue (2016 - 2023)

Item 9 Labs' Current Deferred Revenue history spans 5 years, with the latest figure at $174997.0 for Q2 2023.

  • For Q2 2023, Current Deferred Revenue fell 68.8% year-over-year to $174997.0; the TTM value through Jun 2023 reached $174997.0, down 68.8%, while the annual FY2022 figure was $219992.0, 83.34% up from the prior year.
  • Current Deferred Revenue reached $174997.0 in Q2 2023 per INLB's latest filing, roughly flat from $174997.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $685349.0 in Q2 2021 to a low of $119992.0 in Q3 2021.
  • Average Current Deferred Revenue over 3 years is $294016.9, with a median of $219992.0 recorded in 2022.
  • Peak YoY movement for Current Deferred Revenue: skyrocketed 83.34% in 2022, then tumbled 68.8% in 2023.
  • A 3-year view of Current Deferred Revenue shows it stood at $319992.0 in 2021, then tumbled by 46.88% to $169992.0 in 2022, then increased by 2.94% to $174997.0 in 2023.
  • Per Business Quant, the three most recent readings for INLB's Current Deferred Revenue are $174997.0 (Q2 2023), $174997.0 (Q1 2023), and $169992.0 (Q4 2022).